<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cibrian D</submitter><funding>European Research Council</funding><pagination>985-96</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5146640</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(8)</volume><pubmed_abstract>The activation marker CD69 is expressed by skin γδ T cells. Here we found that CD69 controlled the aryl hydrocarbon receptor (AhR)-dependent secretion of interleukin 22 (IL-22) by γδ T cells, which contributed to the development of psoriasis induced by IL-23. CD69 associated with the aromatic-amino-acid-transporter complex LAT1-CD98 and regulated its surface expression and uptake of L-tryptophan (L-Trp) and the intracellular quantity of L-Trp-derived activators of AhR. In vivo administration of L-Trp, an inhibitor of AhR or IL-22 abrogated the differences between CD69-deficient mice and wild-type mice in skin inflammation. We also observed LAT1-mediated regulation of AhR activation and IL-22 secretion in circulating Vγ9(+) γδ T cells of psoriatic patients. Thus, CD69 serves as a key mediat</pubmed_abstract><journal>Nature immunology</journal><pubmed_title>CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.</pubmed_title><pmcid>PMC5146640</pmcid><funding_grant_id>294340</funding_grant_id><pubmed_authors>Cibrian D</pubmed_authors><pubmed_authors>Punzon C</pubmed_authors><pubmed_authors>Vazquez J</pubmed_authors><pubmed_authors>Saiz ML</pubmed_authors><pubmed_authors>Moreno-Gonzalo O</pubmed_authors><pubmed_authors>Fernandez-Salguero PM</pubmed_authors><pubmed_authors>Sanchez-Madrid F</pubmed_authors><pubmed_authors>de la Fuente H</pubmed_authors><pubmed_authors>Fresno M</pubmed_authors><pubmed_authors>Vicente-Manzanares M</pubmed_authors><pubmed_authors>Sanchez-Diaz R</pubmed_authors><pubmed_authors>Ferrarini A</pubmed_authors><pubmed_authors>Martin P</pubmed_authors><pubmed_authors>Jorge I</pubmed_authors><pubmed_authors>Dauden E</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.</name><description>The activation marker CD69 is expressed by skin γδ T cells. Here we found that CD69 controlled the aryl hydrocarbon receptor (AhR)-dependent secretion of interleukin 22 (IL-22) by γδ T cells, which contributed to the development of psoriasis induced by IL-23. CD69 associated with the aromatic-amino-acid-transporter complex LAT1-CD98 and regulated its surface expression and uptake of L-tryptophan (L-Trp) and the intracellular quantity of L-Trp-derived activators of AhR. In vivo administration of L-Trp, an inhibitor of AhR or IL-22 abrogated the differences between CD69-deficient mice and wild-type mice in skin inflammation. We also observed LAT1-mediated regulation of AhR activation and IL-22 secretion in circulating Vγ9(+) γδ T cells of psoriatic patients. Thus, CD69 serves as a key mediat</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Aug</publication><modification>2025-04-18T18:25:51.382Z</modification><creation>2019-03-27T02:31:11Z</creation></dates><accession>S-EPMC5146640</accession><cross_references><pubmed>27376471</pubmed><doi>10.1038/ni.3504</doi></cross_references></HashMap>